Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors

Archives of Gynecology and Obstetrics

Volumn 287, Issue 5, 2013, Pages 989-995

  Yang, Guofen ^a   Zhang, Haihong ^b   Liu, Yu ^c   Zhou, Juan ^a   He, Weipeng ^a   Quick, Charles M ^b   Xie, Dan ^d   Smoller, Bruce R ^b   Fan, Chun Yang ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c Infertility Research Center   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Clusterin; Methylation; Ovarian tumors; Protein expression

Indexed keywords

CLUSTERIN;

ADULT; AGED; ARTICLE; BORDERLINE OVARIAN TUMOR; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERMETHYLATION; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESENTERIC METASTASIS; METHYLATION; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVARY CARCINOMA; OVARY METASTASIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLUSTERIN; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MESENTERY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PROMOTER REGIONS, GENETIC; TISSUE ARRAY ANALYSIS;

EID: 84876691068     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2650-6     Document Type: Article

References (21)

1. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK (1998) Cancer incidence and mortality.1973-1995: a report card for the US. Cancer 82:1197-1207 (Pubitemid 28136536)
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66 (Pubitemid 46148091)
3. Lynch HT, Casey MJ, Lynch J, White TE, Godwin AK (1998) Genetics and ovarian carcinoma. Semin Oncol 25:265-280 (Pubitemid 28272602)
4. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U (2006) Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):S161-S192 (Pubitemid 44854933)
5. DiSaia PJ, Bloss JD (2003) Treatment of ovarian cancer: new strategies. Gynecol Oncol 90:S24-S32
6. Blaschuk O, Burdzy K, Fritz IB (1983) Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram testis fluid. J Biol Chem 258:7714-7720 (Pubitemid 13038010)
7. Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34:427-431 (Pubitemid 34242756)
8. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J (2006) Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13:12-19
9. Rosenberg ME, Silkensen J (1995) Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Bio 27:633-645
10. Lau SH et al (2006) Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 25:1242-1250
11. Yang GF, Li XM, Xie D (2009) Overexpression of clusterin in ovarian cancer is correlated with impaired survival. Int J Gynecol Cancer 19:1342-1346
12. Wolffe AP, Matzke MA (1999) Epigenetics: regulation through repression. Science 286:481-486
13. Jones PA, Laird PW (1999) Cancer epigenetics comes of age (Review). Nat Genet 21:163-167 (Pubitemid 29070360)
14. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future (Review). Oncogene 21:5427-5440 (Pubitemid 34983479)
15. Herman JG et al (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704 (Pubitemid 24311875)
16. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530
17. Widschwendter M, Jones PA (2002) DNA methylation and breast carcinogenesis (Review). Oncogene 21:5462-5482 (Pubitemid 34983482)
18. Lund P et al (2006) Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. Oncogene 25:4890-4903 (Pubitemid 44201180)
19. Serrano A, Redondo M, Tellez T, Castro-Vega I, Roldan MJ, Mendez R, Rueda A, Jimenez E (2009) Regulation of clusterin expression in human cancer via DNA methylamine. Tumor Biol 30:286-291
20. Djeu JY, Wei S (2009) Clusterin and chemoresistance (Review). Adv Cancer Res 105:77-92
21. Fratelli M, Galli G, Minto M, Pasinetti GM (1996) Role of clusterin in cell adhesion during early phases of programmed cell death in P19 embryonic carcinoma cells. Biochim et Biophys Acta 1311:71-76 (Pubitemid 26143647)